BMRN vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

BMRN

59.0
AI Score
VS
BMRN Wins

MRNA

36.3
AI Score

Investment Advisor Scores

BMRN

59score
Recommendation
HOLD

MRNA

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BMRN MRNA Winner
Revenue 1.76B 534.00M BMRN
Net Income 150.29M -2.13B BMRN
Net Margin 8.6% -397.9% BMRN
Operating Income 240.56M -2.20B BMRN
ROE 2.4% -31.4% BMRN
ROA 1.3% -19.4% BMRN
Total Assets 11.72B 10.96B BMRN
Cash 874.00M 1.72B MRNA
Debt/Equity 0.66 0.09 MRNA
Current Ratio 2.39 2.29 BMRN
Free Cash Flow 339.02M -1.25B BMRN

Relative Price Performance (Last 90 Days)

BMRN 1M: -14.1% · 3M: -2.1% MRNA 1M: +25.5% · 3M: +131.5%

Current Technical Phase

BMRN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 27.6 · Price: $57.56

MRNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (47.6% over 20 days), RSI 66

RSI (14): 66.0 · Price: $189.33

Fundamentals Snapshot

Metric BMRN MRNA
Market Cap — —
Forward P/E 8.6 -39.7
Trailing P/E 157.9 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.5% -0.7%
Operating Margin 0.2% -5.6%
EPS 0.37 -7.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BMRN is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.